Taking people in Olaszország1/2. fázis
Phase 1b/2 trial of 5-fluorouracil, leucovorin, irinotecan in combination with temozolomide (FLIRT) and bevacizumab for the first-line treatment of patients with MGMT silenced, microsatellite stable metastatic colorectal cancer.
Key facts
- Where
- Faenza, Milan, Padova, Pisa, Rome és Udine, OlaszországSee the 6 sites
- Phase
- 1/2. fázis
Where in Olaszország
- Azienda Unita Sanitaria Locale Della RomagnaFaenza, OlaszországTaking people
- Fondazione IRCCS - Istituto Nazionale dei TumoriMilan, OlaszországTaking people
- Istituto Oncologico VenetoPadova, OlaszországTaking people
- Azienda Ospedaliero Universitaria PisanaPisa, OlaszországTaking people
- Fondazione Policlinico Universitario Agostino Gemelli IRCCSRome, OlaszországTaking people
- Azienda Sanitaria Universitaria Friuli CentraleUdine, OlaszországTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Fondazione IRCCS Istituto Nazionale Dei Tumori
- Trial code
- EU 2024-515580-64-00
- Record updated
- 2025. december 22.